Leo Pharma AS - Company Profile
Powered by 
All the data and insights you need on Leo Pharma AS in one report.
$295
- Save hours of research time and resources with
our up-to-date Leo Pharma AS Strategy Report
- Understand Leo Pharma AS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
LEO Pharma AS (LEO Pharma), a subsidiary of LEO Foundation, is a drug manufacturing company. It discovers, develops, manufactures, and commercializes medicines for skin diseases and thrombosis. Its product portfolio spans pharmaceuticals for the treatment of diseases such as eczema, psoriasis, skin infections, actinic keratosis, non-melanoma skin cancer, and thrombosis. The company also manufactures and markets products for the treatment of bacterial infections, coagulation, cardiovascular, antibiotics, nutritional disorders, osteoporosis, and renal problems. LEO Pharma markets its products worldwide. The company has a presence in Europe, the Middle East, Africa, Asia, the Americas, and Oceania. LEO Pharma is headquartered in Ballerup, Denmark.
Headquarters
Denmark
Address
Industriparken 55, Ballerup, 2750
Website
www.leo-pharma.com
Telephone
45 44 945888
No of Employees
5,252
Industry
Pharmaceuticals and Healthcare
Revenue (2022)
$1.5B
Leo Pharma AS premium industry data and analytics
Products and Services
| Products |
|---|
| Psoriasis: |
| Kyntheum |
| Enstilar |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Asset Purchase | In January, the company acquired strategic asset TMB-001 and certain other assets from Timber Pharmaceuticals. |
| 2023 | Contracts/Agreements | In August, the company entered into an agreement to acquire Timber Pharmaceuticals for US$36 million. |
| 2023 | Contracts/Agreements | In March, the company entered into an partnership agreement with ICON to accelerate the implementation of clinical trials in the field of medical dermatology. |
Competitor Comparison
| Key Parameters | Leo Pharma AS | Teva Pharmaceutical Industries Ltd | Bausch Health Companies Inc | UCB SA | Galderma SA |
|---|---|---|---|---|---|
| Headquarters | Denmark | Israel | Canada | Belgium | Switzerland |
| City | Ballerup | Tel Aviv | Laval | Anderlecht | Zug |
| State/Province | - | Tel Aviv | Quebec | - | - |
| No. of Employees | 5,252 | 35,001 | 20,270 | 9,083 | 5,700 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jesper Brandgaard | Chairman | Executive Board | 2021 | - |
| Christophe Bourdon | Chief Executive Officer | Senior Management | 2022 | - |
| Philip Eickhoff | Chief Financial Officer; Executive Vice President - Global Finance and Business Services | Senior Management | 2022 | - |
| Jacob Pontoppidan Thyssen | Chief Scientific Officer; Vice President | Senior Management | 2023 | - |
| Kreesten Meldgaard Madsen | Chief Development Officer | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer